Who
Michael Harsh
Director
Company insider
Files Form 4 as: Director, ENDRA Life Sciences; Director, Compute Health Acquisition.
In numbers
- Trades disclosed
- 31
- Buys
- 4
- Sells
- 0
- Bought
- $11K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 12 May 2017
- Last trade
- 21 Jan 2026
- Last filed
- 23 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —60,324 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —60,324 at $0.00 | filing |
| 11 Jun 2025filed 1 Jul 2025 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —5,384 at $0.00 | filing |
| 2 Jan 2024filed 23 Feb 2024 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —600 at $0.00 | filing |
| 1 Aug 2023filed 3 Aug 2023 | Compute Health Acquisitionoption or derivative | SEC FORM 4 Code D | —30,000 | filing |
| 1 Aug 2023filed 3 Aug 2023 | Compute Health Acquisitionoption or derivative | SEC FORM 4 Code D | —2,500 | filing |
| 1 Aug 2023filed 3 Aug 2023 | Compute Health Acquisition | SEC FORM 4 Code A | —21,120 | filing |
| 1 Aug 2023filed 3 Aug 2023 | Compute Health Acquisition | SEC FORM 4 Code D | —31,120 | filing |
| 30 Jan 2023filed 1 Feb 2023 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —9,634 at $0.00 | filing |
| 28 Mar 2022filed 30 Mar 2022 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —109,492 at $0.00 | filing |
| 3 Jan 2022filed 4 Jan 2022 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 5 Apr 2021filed 7 Apr 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 4 Jan 2021filed 25 Mar 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 23 Jun 2020filed 24 Jun 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code X | —5,000 at $0.00 | filing |
| 23 Jun 2020filed 24 Jun 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code X | $4,3505,000 at $0.87 | filing |
| 8 Jun 2020filed 10 Jun 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code C | $11K9.62 at $1,143.68 | filing |
| 8 Jun 2020filed 10 Jun 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code C | $9,90611,386 at $0.87 | filing |
| 9 Apr 2020filed 13 Apr 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —42,857 at $0.00 | filing |
| 2 Jan 2020filed 6 Jan 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 11 Dec 2019filed 11 Dec 2019 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —89,922 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.